Back to Search Start Over

Comment on: 'Mapping the Paediatric Quality of Life Inventory (PedsQL (TM)) Generic Core Scales Onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children'

Authors :
Lambe, T
Frew, E
Ives, NJ
Woolley, RL
Cummins, C
Brettell, EA
Barsoum, EN
Webb, NJA
Prednos Trial Team
Ray, DW
Ray, D
Source :
PHARMACOECONOMICS
Publication Year :
2018

Abstract

The Paediatric Quality of Life Inventory (PedsQL™) questionnaire is a widely used, generic instrument designed for measuring health-related quality of life (HRQoL); however, it is not preference-based and therefore not suitable for cost-utility analysis. The Child Health Utility Index-9 Dimension (CHU-9D), however, is a preference-based instrument that has been primarily developed to support cost-utility analysis.This paper presents a method for estimating CHU-9D index scores from responses to the PedsQL™ using data from a randomised controlled trial of prednisolone therapy for treatment of childhood corticosteroid-sensitive nephrotic syndrome.HRQoL data were collected from children at randomisation, week 16, and months 12, 18, 24, 36 and 48. Observations on children aged 5 years and older were pooled across all data collection timepoints and were then randomised into an estimation (n = 279) and validation (n = 284) sample. A number of models were developed using the estimation data before internal validation. The best model was chosen using multi-stage selection criteria.Most of the models developed accurately predicted the CHU-9D mean index score. The best performing model was a generalised linear model (mean absolute error = 0.0408; mean square error = 0.0035). The proportion of index scores deviating from the observed scores by 13 years) or patient groups with particularly poor quality of life.16645249.

Details

Language :
English
Database :
OpenAIRE
Journal :
PHARMACOECONOMICS
Accession number :
edsair.doi.dedup.....a5e12bb29327e04cf0bc8ae576777b99